The European sector urges the EU to avoid new restrictions and to conclude a coherent, sci... 03/12/2025 Climate change Agrifood Food & feed Agriculture Gene editing The third and final round of trilogues begins to finalize an agreement on the Regulation on plants obtained through New... AseBio
The European sector urges the EU to avoid new restrictions and to conclude a coherent, sci... 03/12/2025 The third and final round of trilogues begins to finalize an agreement on the Regulation on plants obtained through New... AseBio
Integra Therapeutics part of Spanish Government presentation of ‘HispanIA 2040’ as an AI f... 28/01/2025 Healthcare Access to innovation Personalized medicine Gene editing HispanIA 2040 is a strategic study promoted by the Spanish National Office of Foresight and Strategy, compiled by 12... Partners - Integra Therapeutics S.L.
Biotechnology and DNA: The duo paving the way for the era of customization in health and a... 25/04/2024 Healthcare Access to innovation Innovative drugs Personalized medicine Agrifood Food & feed Gene editing Next-generation DNA sequencing has a significant impact on personalized medicine, genomic research, and the... AseBio
Biotechnology and DNA: The duo paving the way for the era of customization in health and a... 25/04/2024 Next-generation DNA sequencing has a significant impact on personalized medicine, genomic research, and the... AseBio
Where to find BIAT GROUP in March 2024 🔎 05/03/2024 Healthcare Climate change Agrifood Gene editing International Communication Corporate 2024 Smart Agrifood Summit; TRANSFIERE 2024, 3rd European Meeting on Science, Technology and Innovation! Partners - Biotechnology Assets
VIVEbiotech has received the "Business Innovation" award at the XXXII edition of the Basqu... 24/10/2023 Healthcare Innovative drugs Personalized medicine Advanced therapies VIVEbiotech has received the "Innovacion Empresarial/Business Innovation" award at the XXXII edition of the La Noche de... Partners - VIVEbiotech
VIVEbiotech participates in the European MAGIC project 11/07/2023 Healthcare Personalized medicine Advanced therapies Gene editing International EU projects Financing VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to commercial scale. It is... Partners - VIVEbiotech
Canadian Intelectual Property Office (CIPO) has conceded ZIP Solutions “Split Inteins and ... 24/03/2023 Healthcare Access to innovation In vitro diagnostics Drug discovery Rare diseases Innovative drugs Personalized medicine Advanced therapies Gene editing International The tool has many biotech applications Partners - Biotechnology Assets
Integra Therapeutics secures €4.5-million in funding from AdBio Partners, Invivo Capital ... 19/01/2022 Advanced therapies Gene editing Integra is a biotechnology company that is creating next-generation gene writing tools to boost the efficiency and... Partners - Integra Therapeutics S.L.
